Cargando…
Personalized cancer vaccination in head and neck cancer
Cancer is characterized by an accumulation of somatic mutations that represent a source of neoantigens for targeting by antigen‐specific T cells. Head and neck squamous cell carcinoma (HNSCC) has a relatively high mutation burden across all cancer types, and cellular immunity to neoantigens likely p...
Autores principales: | Shibata, Hirofumi, Zhou, Liye, Xu, Na, Egloff, Ann Marie, Uppaluri, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935792/ https://www.ncbi.nlm.nih.gov/pubmed/33368875 http://dx.doi.org/10.1111/cas.14784 |
Ejemplares similares
-
Epigenetic modulation of immunotherapy and implications in head and neck cancer
por: Zhou, Liye, et al.
Publicado: (2021) -
Integrating CD4(+) T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
por: Zhou, Liye, et al.
Publicado: (2022) -
Genomically personalized therapy in head and neck cancer
por: Aung, Kyaw L., et al.
Publicado: (2016)